Telomere length and telomerase catalytic subunit expression in non-astrocytic gliomas

Pathology Research and Practice

Volumn 196, Issue 10, 2000, Pages 691-699

  Chong, Edith Y Y ^a   Pang, Jesse C S ^a   Ko, Chun Wai ^a   Poon, Wai Sang ^a   Ng, Ho Keung ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

hTEP1; hTERT; Non astrocytic gliomas; Telomerase; Telomere length

Indexed keywords

PROTEIN P16; RNA DIRECTED DNA POLYMERASE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL IMMORTALIZATION; CLINICAL ARTICLE; ENZYME ACTIVATION; ENZYME REGULATION; ENZYME SUBUNIT; GENE EXPRESSION; GLIOMA; HUMAN; HUMAN TISSUE; OLIGODENDROGLIOMA; TELOMERE;

EID: 0033759255     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(00)80121-1     Document Type: Article

References (37)

1. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization
2. Extension of life-span by introduction of telomerase into normal human cells
3. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines
4. Telomere elongation in immortal human cells without detectable telomerase activity
5. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
6. Telomerase expression in gliomas including the nonastrocytic tumors
7. The RNA component of human telomerase
8. A mammalian telomerase-associated protein
9. Telomere reduction in human colorectal carcinoma and with agegin
10. Telomerase activity and alterations in telomere length in human brain tumors
11. Correlating telomerase activity levels with human neuroblastoma outcomes
12. Telomerase activity is detected in pancreatic cancer but not in benign tumors
13. Telomerase activity in small-cell and non-small-cell lung cancers
14. Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
15. Predictive value of p53 and pRb immunostaining in locally advanced bladder cancer treated with cystectomy
16. Specific association of human telomerase activity with immortal cells and cancer
17. Both Rb/p16(INK4a) inactivation and telomerase activity are required to immortalize human epithelial cells
18. Telomerase activity in human brain tumours
19. CDKN2/p16 predicts survival in oligodendrogliomas: Comparison with astrocytomas
20. Expression of telomerase RNA, telomerase activity, and telomere length in human gliomas
21. Telomerase catalytic subunit homologs from fission yeast and human
22. Telomerase activation by hTERT in human normal fibroblasts and hepatocellular carcinomas
23. Changes of telomere lengths in human intracranial tumours
24. Brain tumours: The local experience 1984-1992
25. Design and testing of β-actin primers for RT-PCR that do not co-amplify processed pseudogenes
26. Immortalized cells with no detectable telomerase activity. A review
27. Telomeres, telomerase and immortality
28. Alterations in p53 and p16(INK4a) expression and telomere length during spontaneous immortalization of Li-Frameni Syndrome fibroblasts
29. Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors
30. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas
31. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer
32. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated
33. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts
34. Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas
35. Telomere length regulation in mice is linked to a novel chromosome locus